Molecular Mechanism of Mutant CALR-Mediated Transformation
- PMID: 27045016
- PMCID: PMC4832981
- DOI: 10.1158/2159-8290.CD-16-0238
Molecular Mechanism of Mutant CALR-Mediated Transformation
Abstract
Elf and colleagues used an elegant series of functional and biochemical assays to investigate the molecular mechanism of mutant calreticulin (CALR)-driven cellular transformation in myeloproliferative neoplasms (MPN). Mutant CALR is sufficient to induce MPN in mouse transplantation experiments, and transformation is dependent upon physical interaction mediated by the positive electrostatic charge of the mutant CALR C-terminal domain and the thrombopoietin receptor MPL.
©2016 American Association for Cancer Research.
Conflict of interest statement
The authors declare that they do not have any relevant conflicts of interest.
Figures
Comment on
-
Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.Cancer Discov. 2016 Apr;6(4):368-81. doi: 10.1158/2159-8290.CD-15-1434. Epub 2016 Mar 7. Cancer Discov. 2016. PMID: 26951227 Free PMC article.
References
-
- Tefferi A. Myeloproliferative neoplasms: A decade of discoveries and treatment advances. American journal of hematology. 2016;91:50–8. - PubMed
-
- Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006;108:3472–6. - PubMed
-
- Tefferi A, Pardanani A. Myeloproliferative Neoplasms: A Contemporary Review. JAMA Oncology. 2015;1:97–105. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
